ELN » Topics » Revenue from the EDT Business

This excerpt taken from the ELN 6-K filed Aug 28, 2009.
Revenue from the EDT Business
 
Revenue from the EDT business unit slightly decreased to $138.6 million in the first half of 2009 from $139.1 million in the first half of 2008.
 
                 
    Six Months Ended 30 June  
    2009     2008  
    $m     $m  
 
TriCor® 145
    30.0       28.8  
Focalin® XR/Ritalin®LA
    17.6       17.2  
Skelaxin®
    15.6       17.4  
Verelan®
    10.8       11.2  
Other
    52.1       55.3  
                 
Total product revenue — manufacturing revenue and royalties
    126.1       129.9  
Contract revenue
    12.5       9.2  
                 
Total revenue from the EDT business
    138.6       139.1  
                 
 
Manufacturing revenue and royalties comprise revenue earned from products we manufacture for clients and royalties earned principally on sales by clients of products that incorporate our technologies.


9


Table of Contents

Manufacturing revenue and royalties decreased 3% to $126.1 million in the first half of 2009 from $129.9 million in the first half of 2008. The decrease reflects the impact of the timing of customer orders. Except as noted above, no other single product accounted for more than 10% of our manufacturing revenue and royalties in either the first half of 2009 or 2008. For the first half of 2009, 46% (2008: 45%) of these revenues consisted of royalties received on products that we do not manufacture.
 
Potential generic competitors have challenged the existing patent protection for several of the products from which we earn manufacturing revenue and royalties. We and our clients defend our intellectual property rights vigorously. However, if these challenges are successful, our manufacturing revenue and royalties will be materially and adversely affected.
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki